Author(s): Jorgensen AL, Al-Zubiedi S, Zhang JE, Keniry A, Hanson A, Hughes DA, van Eker D, Stevens L, Hawkins K, Toh CH, Kamali F, Daly AK, Fitzmaurice D, Coffey A, Williamson PR, Park BK, Deloukas P, Pirmohamed M
Keywords: dosing algorithms haemorrhage pharmacogenetics variability warfarin REDUCTASE COMPLEX SUBUNIT-1 VITAMIN-K ANTAGONISTS COAGULATION-FACTOR-IX BLEEDING COMPLICATIONS DOSE REQUIREMENTS INTERINDIVIDUAL VARIABILITY ATRIAL-FIBRILLATION ELDERLY-PATIENTS CYP2C9 VKORC1
|
Professor Ann Daly
|
|